ULTRALIFE CORP (ULBI) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
ULBI currently has 16.7M outstanding shares. with significant dilution risk as 22.6M authorized shares could dilute existing holders by 135.6%. The company has minimally diluted shareholders by 0.98% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 08, 2026 |
10-Q filing | 16.7M shares outstanding |
17M | 23M |
| Mar 23, 2026 |
10-K filing | 16.6M shares outstanding |
17M | 23M |
| Nov 17, 2025 |
10-Q filing | 16.6M shares outstanding |
17M | 23M |
| Aug 07, 2025 |
10-Q filing | 16.6M shares outstanding |
17M | 23M |
| May 12, 2025 |
10-Q filing | 16.6M shares outstanding |
17M | 23M |
| Apr 01, 2025 |
10-K filing | 16.6M shares outstanding |
17M | 23M |
| Nov 12, 2024 |
10-Q filing | 16.6M shares outstanding |
17M | 23M |
| Jul 25, 2024 |
10-Q filing | 16.6M shares outstanding |
17M | 23M |
| May 02, 2024 |
S-3/A filing: This S-3/A filing from 2024-05-02 concerns the offering of securities under a registration statement on Form S-3, with estimated expenses to be included in the applicable prospectus supplement. |
17M | 23M |
| Apr 25, 2024 |
10-Q filing | 16.5M shares outstanding |
17M | 23M |
| Mar 29, 2024 |
S-3 filing: Ultralife Corporation may offer and sell common stock, preferred stock, warrants, and units up to an aggregate initial offering price of $100 million under a shelf registration. |
16M | 23M |
| Mar 21, 2024 |
10-K filing | 16.2M shares outstanding |
16M | 12M |
| Oct 26, 2023 |
10-Q filing | 16.3M shares outstanding |
16M | 12M |
| Jul 27, 2023 |
10-Q filing | 16.1M shares outstanding |
16M | 12M |
| May 04, 2023 |
10-Q filing | 16.1M shares outstanding |
16M | 12M |
| Mar 31, 2023 |
10-K filing | 16.1M shares outstanding |
16M | 12M |
| Oct 27, 2022 |
10-Q filing | 16.1M shares outstanding |
16M | 12M |
| Jul 28, 2022 |
10-Q filing | 16.1M shares outstanding |
16M | 12M |
| Apr 28, 2022 |
10-Q filing | 16.1M shares outstanding |
16M | 12M |
| Mar 08, 2022 |
10-K filing | 16.1M shares outstanding |
16M | 12M |
| Oct 28, 2021 |
10-Q filing | 16.1M shares outstanding |
16M | 12M |
| Jul 29, 2021 |
10-Q filing | 16.0M shares outstanding |
16M | 12M |
| Apr 29, 2021 |
10-Q filing | 16.0M shares outstanding |
16M | 12M |
| Mar 30, 2021 |
S-3 filing: Ultralife Corporation may from time to time offer and sell any combination of shares of its common stock, preferred stock, warrants to purchase common stock and/or preferred stock, and units up to an aggregate initial offering price of $100.0 million. |
16M | 12M |
| Feb 04, 2021 |
10-K filing | 15.9M shares outstanding |
16M | 0 |
| Oct 29, 2020 |
10-Q filing | 15.9M shares outstanding |
16M | 0 |
| Jul 30, 2020 |
10-Q filing | 15.9M shares outstanding |
16M | 0 |
| Apr 30, 2020 |
10-Q filing | 15.9M shares outstanding |
16M | 0 |
| Feb 06, 2020 |
10-K filing | 15.8M shares outstanding |
16M | 0 |